Evidence map›Paper›PMID 30514832›Full record

ReviewNature communications2018

DNA interference and beyond: structure and functions of prokaryotic Argonaute proteins.

Lidiya Lisitskaya, Alexei A Aravin, Andrey Kulbachinskiy

Open access · goldAbstract readReview
In one paragraph

Review in Nature communications, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 83 papers.

0numbers the graph read from it
0cells of the map it votes in
83citing papers in PubMed
7.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

83 citing papers in PubMed, 168 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. A Mesophilic Argonaute fromBiomolecules · 2025
    Article
  17. Article
  18. An Engineered PfAgo with Wide Catalytic Temperature Range and Substrate Spectrum.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  19. Article
  20. Article

23 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Lidiya LisitskayaInstitute of Molecular Genetics, Russian Academy of Sciences, Moscow, 123182, Russia.
Alexei A AravinInstitute of Molecular Genetics, Russian Academy of Sciences, Moscow, 123182, Russia. aaa@caltech.edu.
Andrey KulbachinskiyInstitute of Molecular Genetics, Russian Academy of Sciences, Moscow, 123182, Russia. akulb@img.ras.ru.
Institute of Molecular Genetics · RUCalifornia Institute of Technology · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recognition and repression of RNA targets by Argonaute proteins guided by small RNAs is the essence of RNA interference in eukaryotes. Argonaute proteins with diverse structures are also found in many bacterial and archaeal genomes. Recent studies revealed that, similarly to their eukaryotic counterparts, prokaryotic Argonautes (pAgos) may function in cell defense against foreign genetic elements but, in contrast, preferably act on DNA targets. Many crucial details of the pAgo action, and the roles of a plethora of pAgos with non-conventional architecture remain unknown. Here, we review available structural and biochemical data on pAgos and discuss their possible functions in host defense and other genetic processes in prokaryotic cells.

Indexed as

Argonaute ProteinsCatalysisCatalytic DomainDNAEukaryotaEukaryotic CellsGenetic EngineeringImmune SystemProkaryotic CellsProtein BindingProtein DomainsProtein Interaction Domains and MotifsRNARNA InterferenceRNA, Small InterferingArgonaute ProteinsDNARNARNA, Small Interfering

Identifiers

PMID30514832
PMCPMC6279821
OpenAlexW2902293045

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.